Koseki Y, Terai C, Moriguchi M, Uesato M, Kamatani N
Institute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan.
Ann Rheum Dis. 2001 Apr;60(4):327-31. doi: 10.1136/ard.60.4.327.
This prospective study was designed to clarify the frequency, causes, and clinical course of renal disease in patients with early rheumatoid arthritis (RA).
235 patients (185 women, mean age 49.4 years) with early RA of less than one year's duration were enrolled and assessed monthly. Proteinuria was defined as a positive dipstick result and microscopic haematuria was defined as the presence of > or =5 red blood cells per high power field. Urinary abnormalities lasting three months or longer were defined as persistent abnormalities.
At entry, 40 patients exhibited haematuria, two had a raised serum creatinine concentration, and none had proteinuria. During the observation period (average 42 months), persistent haematuria was found in 43, persistent proteinuria in 17, and a raised serum creatinine concentration in 14 patients. Persistent proteinuria was caused by drugs in 14 of 17 patients and disappeared in most cases. Risk factors for drug induced proteinuria included a raised C reactive protein and erythrocyte sedimentation rate and age over 50 at entry. Drugs resulted in a raised serum creatinine concentration in eight of 14 patients. The incidence of haematuria at entry did not differ among patients who had been treated with non-steroidal anti-inflammatory drugs, disease modifying antirheumatic drugs, or no drugs. In some patients with isolated haematuria, the haematuria appeared when the activity of RA was high and resolved when it was low.
This study suggests that a raised serum creatinine concentration or persistent proteinuria in patients with early RA is predominantly drug related whereas, in contrast, isolated haematuria is more directly associated with the activity of the disease process.
本前瞻性研究旨在明确早期类风湿关节炎(RA)患者肾脏疾病的发生率、病因及临床病程。
纳入235例病程少于1年的早期RA患者(185例女性,平均年龄49.4岁),每月进行评估。蛋白尿定义为试纸条检测结果阳性,镜下血尿定义为每高倍视野有≥5个红细胞。持续3个月或更长时间的尿液异常定义为持续性异常。
入组时,40例患者出现血尿,2例血清肌酐浓度升高,无患者出现蛋白尿。在观察期(平均42个月)内,43例患者出现持续性血尿,17例出现持续性蛋白尿,14例患者血清肌酐浓度升高。17例持续性蛋白尿患者中有14例由药物引起,多数情况下蛋白尿消失。药物性蛋白尿的危险因素包括C反应蛋白和红细胞沉降率升高以及入组时年龄超过50岁。14例患者中有8例因药物导致血清肌酐浓度升高。入组时血尿的发生率在接受非甾体抗炎药、改善病情抗风湿药或未用药的患者中无差异。在一些孤立性血尿患者中,血尿在RA活动度高时出现,在活动度低时消失。
本研究提示,早期RA患者血清肌酐浓度升高或持续性蛋白尿主要与药物相关,而孤立性血尿则更直接地与疾病进程的活动度相关。